Concourse Financial Group Securities’s Royalty Pharma RPRX Stock Holding History

Concourse Financial Group Securities’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-47	Closed	-$1.41K	–	1641
2024 Q4	$1.41K	Sell	47 -42	-47%	-$1.11K	﹤0.01%	2056
2024 Q3	$2.52K	Sell	89 -237	-73%	-$6.57K	﹤0.01%	1965
2024 Q2	$8.6K	Sell	326 -175	-35%	-$4.85K	﹤0.01%	1722
2024 Q1	$15.2K	Sell	501 -35	-7%	-$1.03K	﹤0.01%	1582
2023 Q4	$15.1K	Buy	536 +152	+40%	+$4.18K	﹤0.01%	1564
2023 Q3	$10.4K	Buy	384 +129	+51%	+$3.83K	﹤0.01%	1631
2023 Q2	$7.84K	Buy	255 +60	+31%	+$2.03K	﹤0.01%	1726
2023 Q1	$7.03K	Buy	+195	New	+$7.23K	﹤0.01%	1770
2020 Q3	–	Sell	-100	Closed	-$4.29K	–	2243
2020 Q2	$5K	Buy	+100	New	+$4.95K	﹤0.01%	1699

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Concourse Financial Group Securities's RPRX Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Royalty Pharma (RPRX) in Q1 2025, closing a stake of 47 shares — an estimated $1.41K sold.

Concourse Financial Group Securities first reported a position in RPRX in Q2 2020 and held it in 9 quarters. The position peaked at $15.2K in Q1 2024. 447 funds tracked by Wall St. Rank hold RPRX as of Q1 2025.

Concourse Financial Group Securities reported no remaining Royalty Pharma position as of Q1 2025 after selling out during the quarter.
Concourse Financial Group Securities sold 47 Royalty Pharma shares in Q1 2025, an estimated $1.41K.
Concourse Financial Group Securities first reported a position in Royalty Pharma in Q2 2020 and held it in 9 quarters.
Concourse Financial Group Securities's Royalty Pharma position peaked at $15.2K in Q1 2024.
447 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.